{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2008"],"condition":["Colorectal Neoplasm","Colorectal Neoplasms"],"disease":["Colorectal Neoplasm","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2055331"],"location":["South Korea"],"study_start_month":["4"],"keyword":["Oxaliplatin","Capecitabine","S-1"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer","description":"The aim of this study is to compare the activity and safety of Oxaliplatin and S-1 (OS) and Oxaliplatin and Capecitabine (XELOX) in patients with advance or recurrent colorectal cancer.","dates":{"creation":"2008-04-15"},"accession":"2055331","cross_references":{"ClinicalTrials___gov":["NCT00677144"]}}